Terbutaline
- Generic Name
- Terbutaline
- Brand Names
- Bricanyl
- Drug Type
- Small Molecule
- Chemical Formula
- C12H19NO3
- CAS Number
- 23031-25-6
- Unique Ingredient Identifier
- N8ONU3L3PG
- Background
Terbutaline was first synthesized in 1966 and described in the literature in the late 1960s and early 1970s. It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.
Terbutaline was granted FDA approval on 25 March 1974.
- Indication
Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.
- Associated Conditions
- Asthma, Bronchospasm, Chronic Cough (CC), Chronic Obstructive Pulmonary Disease (COPD), Cough, Premature Labour, Productive cough
- Associated Therapies
- Airway secretion clearance therapy
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath